US Stock MarketDetailed Quotes
PTPI Petros Pharmaceuticals
- 0.2511
- -0.0114-4.34%
Close Nov 19 16:00 ET
- 0.2511
- 0.00000.00%
Post 20:01 ET
2.51MMarket Cap-66P/E (TTM)
0.2760High0.2501Low87.78KVolume0.2601Open0.2625Pre Close23.11KTurnover0.93%Turnover RatioLossP/E (Static)10.01MShares2.270052wk High0.81P/B2.36MFloat Cap0.220852wk Low--Dividend TTM9.40MShs Float59.5990Historical High--Div YieldTTM9.86%Amplitude0.2208Historical Low0.2630Avg Price1Lot Size
Petros Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.87%1.58M | -28.71%1.42M | -44.84%1.39M | -2.83%5.82M | -145.64%-364.25K | 214.88%1.67M | -52.37%1.99M | 2.14%2.52M | -23.29%5.99M | 192.04%798.1K |
| Operating revenue | -5.87%1.58M | -28.71%1.42M | -44.84%1.39M | -2.83%5.82M | -145.64%-364.25K | 214.88%1.67M | -52.37%1.99M | 2.14%2.52M | -23.29%5.99M | 192.04%798.1K |
| Cost of revenue | -29.74%287.01K | -35.95%329.11K | -39.75%331.83K | -28.75%1.63M | -82.06%158.15K | 42.56%408.48K | -20.85%513.86K | 16.60%550.74K | 43.13%2.29M | 261.60%881.33K |
| Gross profit | 1.83%1.29M | -26.20%1.09M | -46.27%1.06M | 13.19%4.19M | -527.65%-522.4K | 172.59%1.27M | -58.16%1.48M | -1.28%1.97M | -40.39%3.7M | 92.51%-83.23K |
| Operating expense | 12.78%3.63M | -14.45%3.37M | 52.15%4.99M | -23.50%14.95M | 12.40%4.52M | -27.98%3.22M | -24.16%3.94M | -44.12%3.28M | -19.42%19.55M | -41.45%4.02M |
| Selling and administrative expenses | 14.95%2.3M | 1.65%2.29M | 27.26%2.71M | -24.14%9.26M | -1.52%2.88M | -7.79%2M | -30.06%2.25M | -45.34%2.13M | -21.70%12.21M | -30.09%2.92M |
| Research and development costs | 51.21%588.36K | -57.44%368.8K | 387.62%1.56M | 38.43%2.41M | 369.35%834.33K | -47.13%389.09K | 105.72%866.58K | -21.28%319.09K | -2.70%1.74M | -82.02%177.76K |
| Depreciation amortization depletion | -10.56%739.45K | -13.18%717.84K | -13.18%717.84K | -41.36%3.28M | -12.41%802.58K | -47.03%826.8K | -47.03%826.8K | -47.03%826.8K | -18.60%5.6M | -45.83%916.27K |
| -Depreciation and amortization | -10.56%739.45K | -13.18%717.84K | -13.18%717.84K | -41.36%3.28M | -12.41%802.58K | -47.03%826.8K | -47.03%826.8K | -47.03%826.8K | -18.60%5.6M | -45.83%916.27K |
| Operating profit | -19.89%-2.34M | 7.39%-2.28M | -200.03%-3.93M | 32.08%-10.76M | -22.86%-5.04M | 68.58%-1.95M | -48.24%-2.46M | 66.18%-1.31M | 12.20%-15.85M | 48.56%-4.1M |
| Net non-operating interest income expense | -323.30%-82.91K | 105.82%4.88K | 141.67%31.61K | 96.42%-20.83K | 177.83%101.77K | 125.14%37.13K | 44.22%-83.88K | 50.43%-75.85K | -57.82%-581.82K | -1,009.26%-130.75K |
| Non-operating interest income | -55.00%75.82K | 125.59%119.39K | 128.93%151.82K | 3,530.48%515.31K | 1,503.42%227.59K | --168.48K | --52.92K | --66.32K | --14.19K | --14.19K |
| Non-operating interest expense | 20.84%158.73K | -16.29%114.51K | -15.45%120.21K | -10.05%536.14K | -13.19%125.82K | -11.06%131.35K | -9.03%136.8K | -7.10%142.17K | 61.67%596.02K | 1,129.69%144.94K |
| Other net income (expense) | 107.67%202K | 1.61M | 1.73M | 172.58%2.62M | 5.26M | 64.68%-2.63M | -138.28%-3.61M | 0 | ||
| Gain on sale of security | -97.61%202K | --1.61M | --1.73M | 2,880.22%13.71M | --5.26M | --8.45M | ---- | ---- | -95.12%460K | --0 |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---7.46M | --0 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --7.46M | --0 |
| Other non- operating income (expenses) | ---- | ---- | ---- | -427.11%-11.09M | --0 | ---11.09M | ---- | ---- | --3.39M | --0 |
| Income before tax | 51.19%-2.22M | 74.00%-662.03K | -56.13%-2.16M | 59.26%-8.16M | 107.52%318.15K | 67.08%-4.55M | -40.56%-2.55M | -695.04%-1.39M | -122.97%-20.04M | 48.36%-4.23M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.5K |
| Net income | 51.19%-2.22M | 74.00%-662.03K | -56.13%-2.16M | 59.26%-8.16M | 107.54%318.15K | 67.10%-4.55M | -40.56%-2.55M | -695.04%-1.39M | -122.97%-20.04M | 48.43%-4.22M |
| Net income continuous Operations | 51.19%-2.22M | 74.00%-662.03K | -56.13%-2.16M | 59.26%-8.16M | 107.54%318.15K | 67.10%-4.55M | -40.56%-2.55M | -695.04%-1.39M | -122.97%-20.04M | 48.43%-4.22M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 51.19%-2.22M | 74.00%-662.03K | -56.13%-2.16M | 59.26%-8.16M | 107.54%318.15K | 67.10%-4.55M | -40.56%-2.55M | -695.04%-1.39M | -122.97%-20.04M | 48.43%-4.22M |
| Preferred stock dividends | 210.02%1.05M | 216.8K | 595.51K | 821.46K | 482.22K | 339.23K | ||||
| Other preferred stock dividends | 71.11%1.97M | 1.86M | 5.27M | 4.83M | 3.68M | 1.15M | 0 | 0 | 0 | |
| Net income attributable to common stockholders | 13.17%-5.25M | -7.39%-2.73M | -479.50%-8.03M | 31.06%-13.81M | 9.03%-3.84M | 56.31%-6.04M | -40.56%-2.55M | -695.04%-1.39M | -122.97%-20.04M | 48.43%-4.22M |
| Basic earnings per share | 81.40%-0.53 | 69.17%-0.37 | -156.06%-1.69 | 34.40%-6.35 | 20.20%-1.62 | 57.40%-2.85 | -36.36%-1.2 | -725.00%-0.66 | -17.33%-9.68 | 72.75%-2.03 |
| Diluted earnings per share | 81.40%-0.53 | 69.17%-0.37 | -156.06%-1.69 | 34.40%-6.35 | 20.20%-1.62 | 57.40%-2.85 | -36.36%-1.2 | -725.00%-0.66 | -17.33%-9.68 | 72.75%-2.03 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data